|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW SERIES |
Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Liverpool L9 7AL, UK
Correspondence to:
Correspondence to:
Professor P M A Calverley
Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Liverpool L9 7AL, UK; pmacal{at}liverpool.ac.uk
A review of the evidence that the prevention of COPD works and, if so, the effectiveness of this strategy
Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; NAC, N-acetylcysteine
Keywords: chronic obstructive pulmonary disease; exacerbations; prevention
This article has been cited by other articles:
![]() |
J. A. Wedzicha, P. M. A. Calverley, T. A. Seemungal, G. Hagan, Z. Ansari, R. A. Stockley, and for the INSPIRE Investigators The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miravitlles Review: Do we need new antibiotics for treating exacerbations of COPD? Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 61 - 76. [Abstract] [PDF] |
||||
![]() |
R Hubbard The burden of lung disease. Thorax, July 1, 2006; 61(7): 557 - 558. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |